Dow Up 1.31% Nasdaq Up 2.40%

More On IPH.PA

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Innate Pharma S.A. (IPH.PA)

-Paris
6.85 Up 0.42(6.53%) Oct 21
Prev Close:6.85
Open:6.43
Bid:N/A
Ask:6.92
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:6.37 - 6.97
52wk Range:2.33 - 12.30
Volume:455,171
Avg Vol (3m):483,275
Market Cap:362.65M
P/E (ttm):N/A
EPS (ttm):-0.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in EUR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Innate Pharma S.A., a biopharmaceutical company, is engaged in the research and development of pharmaceutical products primarily immunotherapy drug candidates for cancer and inflammatory diseases in France. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback